63. 特発性血小板減少性紫斑病 Idiopathic thrombocytopenic purpura Clinical trials / Disease details

臨床試験数 : 363 / 薬物数 : 212 - (DrugBank : 43) / 標的遺伝子数 : 47 - 標的パスウェイ数 : 138

6 trials found

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2015-005276-14-DK (EUCTR)	08/12/2016	19/10/2016	Maintenance treatment With rituximab in ITP	Prolonging the response by low-dose Rituximab maintenance therapy in immune thrombocytopenia: a rand ...	Immune thrombocytopenia MedDRA version: 23.0;Level: LLT;Classification code 10021245;Term: Idiopathi ...	Trade Name: Mabthera Product Name: rituximab Trade Name: Dexamethasone Abcur Product Name: Dexamethasone ...	Sykehuset Østfold HF	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	130	Phase 3	France;Egypt;Denmark;Norway;Tunisia
2	EUCTR2005-005918-20-FR (EUCTR)	23/12/2008	23/10/2008	Rituximab as second line treatment for ITP:A Multicentre, Randomized, Double blind, Placebo-controll ...	Rituximab as second line treatment for ITP:A Multicentre, Randomized, Double blind, Placebo-controll ...	Immune thrombocytopenic purpura (ITP) MedDRA version: 9.1;Level: LLT;Classification code 10021245;Te ...	Trade Name: MabThera Product Name: MabThera Other descriptive name: RITUXIMAB	Rikshospitalet	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	110	Phase 3	United Kingdom;France;Sweden
3	NCT00475423 (ClinicalTrials.gov)	May 2007	17/5/2007	A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.	An Open Label Study of a Fixed Dose Regimen of MabTheraon Overall Response Rate in Patients With Ref ...	Idiopathic Thrombocytopenic Purpura	Drug: rituximab [MabThera/Rituxan]	Hoffmann-La Roche	NULL	Completed	18 Years	N/A	All	122	Phase 2	Australia
4	NCT00770562 (ClinicalTrials.gov)	July 2005	9/10/2008	A Study Evaluating the Addition of MabThera(Rituximab) to Standard Treatment in Patients With Idiopa ...	A Randomized, Open-label Study of First-line Treatment With Dexamethasone or Dexamethasone Plus MabT ...	Idiopathic Thrombocytopenic Purpura	Drug: rituximab;Drug: Dexamethasone	Hoffmann-La Roche	NULL	Completed	18 Years	N/A	All	103	Phase 3	Italy
5	EUCTR2005-000859-15-IT (EUCTR)	14/04/2005	20/06/2005	Randomized prospective study comparing dexamethasone and dexamethasone plus rituximab in the treatme ...	Randomized prospective study comparing dexamethasone and dexamethasone plus rituximab in the treatme ...	Front-line treatment of adult ITP MedDRA version: 6.1;Level: PT;Classification code 10021245	Trade Name: Mabthera INN or Proposed INN: Rituximab Trade Name: Mabthera INN or Proposed INN: Rituximab ...	ROCHE	NULL	Not Recruiting			Female: yes Male: yes			Italy
6	NCT00909077 (ClinicalTrials.gov)	August 2004	26/5/2009	The Efficacy of Dexamethasone Versus Dexamethasone Combined With Rituximab in Patients With Newly Di ...	A Randomised Phase III Study of the Efficacy of High Dose Dexamethasone Versus High Dose Dexamethaso ...	Idiopathic Thrombocytopenic Purpura	Drug: Dexamethasone;Drug: Dexamethasone and Rituximab	Copenhagen University Hospital at Herlev	NULL	Completed	18 Years	N/A	All	155	Phase 3	Denmark

First Previous1Next Last